Specialty: Reproductive health and childbirth, Primary sub-specialty: Reproductive and Sexual Medicine
Conditions
Interventions
Participants are randomised to one of two groups.
Intervention group: Women are given access to the intervention website, displayed on a ‘tablet’ computer. This consists of:
Sponsors
University London College Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Women 2. Aged 15 to 30 years 3. In need of current or future contraception 4. Attending one of the study sites 5. Able to read English 6. An active email account and access to the internet
Exclusion criteria
Exclusion criteria: 1. Women unable to provide informed consent (e.g. severe learning difficulties) 2. Women needing a language advocate to understand English since the intervention content is intended to be accessed in private
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 28/09/2018: 1. LARC method in use at 6 months, measured by response to study outcome questionnaire 2. Satisfaction with any chosen method of contraception at 6 months, measured by response to study outcome questionnaire using a Likert scale 1-5. How satisfied are you with the contraception you are using currently? Previous primary outcome measures: Follow up rate is measured by completing (in full or in part) the study outcome questionnaire via an online link sent by email 6 months after randomisation, for participants recruited from the general practice, sexual & reproductive health service, abortion services, and community pharmacy), and 2 months post-partum for women recruited from the maternity service. | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 28/09/2018: Quantitative: 1. Follow-up rate at 6 months after randomisation 2. Recruitment rate, measured via the trial website as the time taken to recruit (up to 80) women in each site. Recruitment is assessed by completing (in full or in part) the baseline questionnaire. 3. Effectiveness of contraceptive method in use at 6 months, measured by response to study outcome questionnaire and grouped as follows from least to most effective: no method; withdrawal or natural method; condoms or diaphragm; pill, patch or ring; LARC or sterilisation 4. Change in method between baseline and 6 months, indicating whether any change is to a method of greater, lesser or similar effectiveness (based on grouping above) 5. Pregnancy by 6 months, measured by response to study outcome questionnaire at 3 months and at 6 months 6. Sexually transmitted infection diagnosis by 6 months, measured by response to study outcome questionnaire at 3 months and 6 months 7. Health service and out-of-pocket costs for contraception and other sexual health services, measured by response to study outcome questionnaire at 3 months and at 6 months Qualitative 1. Patient views and experience of the intervention and trial procedures, assessed through qualitative interviews at 2 weeks after randomisation with five women at each study site (total 25 interviews) (See Topic Guide). Questions to be explored include: 1.1. Are the online trial procedures acceptable to participants? E.g. the process of online registration and consent, the receipt of incentives, completing online questionnaires, contact and follow up by email and text 1.2. What are women’s views of the intervention? 1.3. How might trial procedures be improved, to optimise retention in a full-scale tria | — |
Countries
England, United Kingdom
Contacts
Public ContactAnasztazia Gubijev
Outcome results
None listed